Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELTROMBOPAG OLAMINE vs EMAPALUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELTROMBOPAG OLAMINE vs EMAPALUMAB: Safety Overview

Metric ELTROMBOPAG OLAMINE EMAPALUMAB
Total FAERS Reports 16,074 173
Deaths Reported 3,457 63
Death Rate 21.5% 36.4%
Hospitalizations 3,284 84
Average Patient Age 56.5 yrs 17.1 yrs
% Female Patients 57.7% 48.7%
FDA Approval Date Apr 18, 2024 N/A
Manufacturer XLCare Pharmaceuticals Inc. Swedish Orphan Biovitrum AB (publ)
Route ORAL INTRAVENOUS
Marketing Status Prescription N/A